Pharmaceuticals in South Korea

Pharmaceuticals in South Korea


  • Products Id :- OHMF4329
  • |
  • Pages: 41
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pharmaceuticals in South Korea

Summary

Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the South Korea pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The South Korean pharmaceuticals market had total revenues of USD 19.1bn in 2017, representing a compound annual growth rate (CAGR) of 2.3% between 2013 and 2017.

- South Korea has been classed as a developed pharmaceuticals market since 2010. As such it suffers classic problems that other developed markets are experiencing which will lead to increased spending.

- Despite an aging population and being one of the most sophisticated healthcare systems in the world, the value of the pharmaceutical market is only forecast to accelerate slightly throughout the forecast period.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in South Korea

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Korea

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the South Korea pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the South Korea pharmaceuticals market by value in 2017?

- What will be the size of the South Korea pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the South Korea pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in South Korea's pharmaceuticals market?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 16

New entrants 17

Threat of substitutes 19

Degree of rivalry 20

Leading Companies 22

CKD Bio Corporation 22

Daewoong Pharmaceutical Co Ltd 25

Hanmi Science Co., Ltd. 29

Pfizer Inc. 32

Macroeconomic Indicators 36

Country data 36

Methodology 38

Industry associations 39

Related MarketLine research 39

Appendix 40

About MarketLine 40

List of Figures

Figure 1: South Korea pharmaceuticals market value: USD billion, 2013-17

Figure 2: South Korea pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: South Korea pharmaceuticals market share: % share, by value, 2017

Figure 4: South Korea pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in South Korea, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in South Korea, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in South Korea, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2017

Figure 11: CKD Bio Corporation: revenues & profitability

Figure 12: CKD Bio Corporation: assets & liabilities

Figure 13: Daewoong Pharmaceutical Co Ltd: revenues & profitability

Figure 14: Daewoong Pharmaceutical Co Ltd: assets & liabilities

Figure 15: Hanmi Science Co., Ltd.: revenues & profitability

Figure 16: Hanmi Science Co., Ltd.: assets & liabilities

Figure 17: Pfizer Inc.: revenues & profitability

Figure 18: Pfizer Inc.: assets & liabilities

List of Tables

Table 1: South Korea pharmaceuticals market value: USD billion, 2013-17

Table 2: South Korea pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: South Korea pharmaceuticals market share: % share, by value, 2017

Table 4: South Korea pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: CKD Bio Corporation: key facts

Table 6: CKD Bio Corporation: key financials (USD )

Table 7: CKD Bio Corporation: key financials (KRW)

Table 8: CKD Bio Corporation: key financial ratios

Table 9: Daewoong Pharmaceutical Co Ltd: key facts

Table 10: Daewoong Pharmaceutical Co Ltd: key financials (USD )

Table 11: Daewoong Pharmaceutical Co Ltd: key financials (KRW)

Table 12: Daewoong Pharmaceutical Co Ltd: key financial ratios

Table 13: Hanmi Science Co., Ltd.: key facts

Table 14: Hanmi Science Co., Ltd.: key financials (USD )

Table 15: Hanmi Science Co., Ltd.: key financials (KRW)

Table 16: Hanmi Science Co., Ltd.: key financial ratios

Table 17: Pfizer Inc.: key facts

Table 18: Pfizer Inc.: key financials (USD )

Table 19: Pfizer Inc.: key financial ratios

Table 20: South Korea size of population (million), 2013-17

Table 21: South Korea gdp (constant 2005 prices, USD billion), 2013-17

Table 22: South Korea gdp (current prices, USD billion), 2013-17

Table 23: South Korea inflation, 2013-17

Table 24: South Korea consumer price index (absolute), 2013-17

Table 25: South Korea exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 350 INR 25141
Site License
USD 700 INR 50281
Corporate User License
USD 1050 INR 75422

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com